Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, has closed a $14 million series B capitalization led by Harro Höfliger Packaging Systems Inc. and East Seattle Partners. In addition, Experic has added a new investor, Kineticos Ventures.
 
During the past year, Experic has experienced strong growth in demand for its formulation, development, manufacturing and analytical services for hard-to-handle powder drug products as well as its clinical trial supply and logistics services. The funds will be used for continued expansion of capabilities and its facility in Cranbury, New Jersey. With an expert team dedicated to providing personalized service, the company’s flexible approach keeps clients coming back with new projects.
 
“Combined with organic growth, our family of series B investors are instrumental in helping Experic continue its growth trajectory, allowing us to add top talent and make capital investments to expand our capabilities,” said David Wood, chief executive officer and chairman of Experic. “These partners are true supporters of Experic and our commitment to provide a better client experience to biopharmaceutical companies racing to develop innovative therapeutics for patients in need.”